Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin H Lachmann

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Circulation. Cardiovascular Imaging|April 9, 2013
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mappingDaniel M Sado, Steven K White, Stefan K Piechnik, et al.
RMD Open|February 28, 2023
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatmentPeter Kamenicky, Karine Briot, Maria Luisa Brandi, et al.
Heart (British Cardiac Society)|September 1, 2012
Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and diseaseDaniel M Sado, Andrew S Flett, Sanjay M Banypersad, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 6, 2014
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonanceSilvia Pica, Daniel M Sado, Viviana Maestrini, et al.
Molecular Genetics and Metabolism|September 5, 2014
Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosisLinda van der Tol, Einar Svarstad, Alberto Ortiz, et al.
European Journal of Immunology|May 16, 2012
Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type CAnneliese O Speak, Nicholas Platt, Mariolina Salio, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 28, 2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary AnalysisKarl L Insogna, Karine Briot, Erik A Imel, et al.
Journal of Inherited Metabolic Disease|June 20, 2013
Cross-sectional observational study of 208 patients with non-classical urea cycle disordersCorinne M Rüegger, Martin Lindner, Diana Ballhausen, et al.
Gut|March 9, 2016
Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's diseaseTobias Schwerd, Sumeet Pandey, Huei-Ting Yang, et al.
Calcified Tissue International|August 4, 2022
Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 StudyMaria Luisa Brandi, Suzanne Jan de Beur, Karine Briot, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Circulation. Cardiovascular Imaging|April 9, 2013
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mappingDaniel M Sado, Steven K White, Stefan K Piechnik, et al.
RMD Open|February 28, 2023
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatmentPeter Kamenicky, Karine Briot, Maria Luisa Brandi, et al.
Heart (British Cardiac Society)|September 1, 2012
Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and diseaseDaniel M Sado, Andrew S Flett, Sanjay M Banypersad, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 6, 2014
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonanceSilvia Pica, Daniel M Sado, Viviana Maestrini, et al.
Molecular Genetics and Metabolism|September 5, 2014
Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosisLinda van der Tol, Einar Svarstad, Alberto Ortiz, et al.
European Journal of Immunology|May 16, 2012
Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type CAnneliese O Speak, Nicholas Platt, Mariolina Salio, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 28, 2018
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary AnalysisKarl L Insogna, Karine Briot, Erik A Imel, et al.
Journal of Inherited Metabolic Disease|June 20, 2013
Cross-sectional observational study of 208 patients with non-classical urea cycle disordersCorinne M Rüegger, Martin Lindner, Diana Ballhausen, et al.
Gut|March 9, 2016
Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's diseaseTobias Schwerd, Sumeet Pandey, Huei-Ting Yang, et al.
Calcified Tissue International|August 4, 2022
Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 StudyMaria Luisa Brandi, Suzanne Jan de Beur, Karine Briot, et al.
Pageof 6